Search

Search results

33 results found

Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial. 2022 Dec;175(12):1666-1674. doi: 10.7326/M22-1438. Epub 2022 Nov 8. PMID: 36343348

Publication: Journal Article

Camilleri, M, T Subramanian, F Pagan, S Isaacson, R Gil, RA Hauser, M Feldman, and M Goldstein. 2022. “Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial. 2022 Dec;175(12):1666-1674. Doi: 10.7326/M22-1438. Epub 2022 Nov 8. PMID: 36343348”. Ann Intern Med.

The Clinical Development of Levodopa Inhalation Powder. 2023 Mar-Apr 01;46(2):66-78. doi: 10.1097/WNF.0000000000000540. Epub 2023 Jan 29. PMID: 36715241

Publication: Journal Article

Hauser, RA, PA LeWitt, CH Waters, DG Grosset, and B Blank. 2023. “The Clinical Development of Levodopa Inhalation Powder. 2023 Mar-Apr 01;46(2):66-78. Doi: 10.1097/WNF.0000000000000540. Epub 2023 Jan 29. PMID: 36715241”. Clin Neuropharmacol.

Disease Observational Study-Rare Disease Registry-Cross-Registry Analysis

News: September 25, 2024

Sanofi Genzyme Rare Disease Registry - A Multi-Center, International, Longitudinal, Observational program designed to track natural history and outcomes of patients with Gaucher, Fabry, MPSI, and Pompe Disease ( Gaucher registry, Fabry registry, MPSI registry, Pompe registry) International...